Obesity usually induces systemic metabolic disturbances,
including
in the tumor microenvironment (TME). This is because adaptive metabolism
related to obesity in the TME with a low level of prolyl hydroxylase-3
(PHD3) depletes the major fatty acid fuels of CD8+ T cells
and leads to the poor infiltration and unsatisfactory function of
CD8+ T cells. Herein, we discovered that obesity could
aggravate the immunosuppressive TME and weaken CD8+ T cell-mediated
tumor cell killing. We have thus developed gene therapy to relieve
the obesity-related TME to promote cancer immunotherapy. An efficient
gene carrier was prepared by modifying polyethylenimine with p-methylbenzenesulfonyl (abbreviated as PEI-Tos) together
with hyaluronic acid (HA) shielding, achieving excellent gene transfection
in tumors after intravenous administration. HA/PEI-Tos/p
DNA (HPD) containing the plasmid encoding PHD3 (pPHD3) can
effectively upregulate the expression of PHD3 in tumor tissues, revising
the immunosuppressive TME and significantly increasing the infiltration
of CD8+ T cells, thereby improving the responsiveness of
immune checkpoint antibody-mediated immunotherapy. Efficient therapeutic
efficacy was achieved using HPD together with αPD-1
in colorectal tumor and melanoma-bearing obese mice. This work provides
an effective strategy to improve immunotherapy of tumors in obese
mice, which may provide a useful reference for the immunotherapy of
obesity-related cancer in the clinic.
In a 2013 article, I partitioned all musical contours into fifteen types and arranged them in a network called the minimally divergent contour network (MDCN). Within the MDCN, we can examine the similarity between any two contour types by measuring the shortest path between them. However, despite the methodological efficiency, none of the fifteen types considers nonconsecutive repeated contour pitches. Prompted by this issue, this article extends the MDCN to include nonconsecutive repeated contour pitches. To demonstrate the analytic utility of the extended MDCN, I examine works by Bright Sheng and György Kurtág.
To make post-tonal harmony more accessible, many music scholars derive various theories, which rely on the traditional notions of consonance and dissonance, to describe the quality of a chord. Most of these theories use the quality of an interval as the criterion to measure the proportion between the consonances and dissonances within a chord. All intervals can be categorized as either consonances or dissonances except for one-the tritone. Although traditionally in tonal music, the tritone was perceived as a dissonance; its quality in twentieth-century music, however, has been challenged by many scholars. It may sound like a dissonant (Paul Hindemith), a consonant ( Joseph Straus), or a neutral interval (Charles Seeger). If different viewpoints abound in the tritone's quality, do we hear it as adding the consonant or dissonant sound to a chord? Confronted with this issue, this article suggests an alternative way of perceiving all intervals-their space-and further proposes a method that assists us in hearing a chord in terms of its degree of compactness. Based on this method, we can experience the dynamics created by the confrontation between spatial and compact chords, and find post-tonal harmony more accessible.
Ce document est protégé par la loi sur le droit d'auteur. L'utilisation des services d'Érudit (y compris la reproduction) est assujettie à sa politique d'utilisation que vous pouvez consulter en ligne. https://apropos.erudit.org/fr/usagers/politique-dutilisation/ Cet article est diffusé et préservé par Érudit.Érudit est un consortium interuniversitaire sans but lucratif composé de l'
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.